You're contacting media contact of this press release

Title: CoreAge Rx Announces the Launch of a New Flat-Rate GLP-1 Weight Management Programme

Wichita Falls, TX, United States, 13th Jun 2026 - CoreAge Rx has officially announced the launch of its new GLP-1 weight management product, now accessible to patients nationwide through a dedicated platform at https://try.coreagerx.com/glp-supp-sp. This new service delivers compounded GLP-1 medications, specifically semaglutide and tirzepatide, through a modernised telehealth framework designed to simplify the patient experience. By combining physician-guided care, transparent pricing, and rapid delivery logistics, the company provides a predictable and accessible pathway for long-term weight management.The introduction of this product directly addresses the widespread issue of fluctuating and unpredictable costs in healthcare. Patients seeking weight management treatments often face unexpected price increases as their dosage requirements change over time. CoreAge Rx has structured a flat-rate pricing model to eliminate these financial uncertainties. Through the new platform, patients can access compounded semaglutide starting at an annual equivalent of $99 per month, and compounded tirzepatide starting at $149 per month. Crucially, these rates remain constant across all therapeutic dosage levels. Whether a patient requires a starting dose or the maximum prescribed amount, the monthly cost remains identical, with no hidden membership fees, consultation charges, or shipping costs.Accessibility and convenience form the foundation of this new product launch. The traditional healthcare model often requires multiple in-person appointments, pharmacy collections, and administrative delays. CoreAge Rx has transitioned this entire process into a secure, streamlined digital environment. Prospective patients begin the process by completing a straightforward online health assessme...

This press release is issued by King Newswire